NBD-Cl (=4-Chloro-7-nitro-2,1,3-benzoxadiazole) [for HPLC Labeling]>98.0%(T)5g

4-Bromo-3-chlorophenol, 98.0%, 10g

2-Methoxypyrimidin-5-amine, 97.0%, 250mg

Ethyl 2-Bromobenzoate>98.0%(GC)25g

2-Bromo-6-chloro-1,7-naphthyridine, 95%, 250mg

Methyl 2-chloro-5-fluoronicotinate, 95.0%, 5g

tert-Butyl (2-chloropyrimidin-5-yl)carbamate, 100mg

n-Decyltriethoxysilane, 98%, 100g

Methyl hydrazinocarboxylate, 98.00%, 100g

Cyclopropylmethyl bromide, 98.0%, 10g

2-Bromo-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 250mg

b-(4-Methylbenzyl)mercapto-b,b-cyclopenta-methylene-propionic acid, 99.0%, 5g

N-(6-(3-(TERT-BUTYL)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-2-METHOXYPHENYL)NAPHTHALEN-2-YL)METHANESULFONAMIDE, 98%, 250mg